[HTML][HTML] Peripheral polyneuropathy in severely obese patients with metabolic syndrome but without diabetes: Association with low HDL-cholesterol
OH Nienov, L Matte, LS Dias, H Schmid - Revista da Associação …, 2017 - SciELO Brasil
OH Nienov, L Matte, LS Dias, H Schmid
Revista da Associação Médica Brasileira, 2017•SciELO BrasilIntroduction: The purpose of this study was to evaluate the prevalence of peripheral
polyneuropathy (PPN) in subjects with grade II and III obesity (Ob-II, III) and metabolic
syndrome (MetS) but without diabetes and to investigate possible associated factors.
Method: A cross-sectional study was performed in non-diabetic Ob-II, III, MetS patients using
the Michigan Neuropathy Screening Instrument (MNSI) to assess the presence of PPN.
Results: A total of 24 of 218 non-diabetic Ob-II, III, MetS patients had PPN. Based on …
polyneuropathy (PPN) in subjects with grade II and III obesity (Ob-II, III) and metabolic
syndrome (MetS) but without diabetes and to investigate possible associated factors.
Method: A cross-sectional study was performed in non-diabetic Ob-II, III, MetS patients using
the Michigan Neuropathy Screening Instrument (MNSI) to assess the presence of PPN.
Results: A total of 24 of 218 non-diabetic Ob-II, III, MetS patients had PPN. Based on …
Introduction
The purpose of this study was to evaluate the prevalence of peripheral polyneuropathy (PPN) in subjects with grade II and III obesity (Ob-II,III) and metabolic syndrome (MetS) but without diabetes and to investigate possible associated factors.
Method
A cross-sectional study was performed in non-diabetic Ob-II,III,MetS patients using the Michigan Neuropathy Screening Instrument (MNSI) to assess the presence of PPN.
Results
A total of 24 of 218 non-diabetic Ob-II,III,MetS patients had PPN. Based on univariate analysis, serum levels of LDL-cholesterol (p=0.046) were significantly associated with PPN, while serum triglycerides (p=0.118) and low HDL-cholesterol (p=0.057) showed a tendency toward this association. On a Poisson regression analysis, when the three possible associations were included, low HDL-cholesterol (p=0.047) remained independently associated.
Conclusion
In non-diabetic Ob-II,III,MetS patients, PPN defined by the MNSI showed a high prevalence and was associated with low levels of HDL-cholesterol. In order to diagnose that complication, neurological evaluation should be performed in these patients.
SciELO Brasil
